Evaluating of HPV–DNA ISH as an adjunct to p16 testing in oropharyngeal cancer

Aim: Current guidelines recommend p16 immunohistochemistry (IHC) for testing human papillomavirus (HPV) in oropharyngeal carcinoma (OPSCC). We evaluated the value of adding DNA in situ hybridization (ISH) to p16 IHC. Methods: Fifty patients with OPSCC were analyzed. Concordance between HPV–DNA ISH and p16 IHC was measured by Gwet's agreement coefficient. Results: p16 IHC was positive in 35/48 (72.9%), negative in 8/48 (16.7%) patients. Wide spectrum DNA–ISH was positive in 9/23 (39%) and negative in 14/23 (60.9%) patients. High-risk 16/18 (HR) HPV DNA–ISH was positive in 11/23 (47.8%) and negative in 12 (52.2%) patients. The agreement between HPV DNA–ISH and p16 IHC is fair (Gwet's AC1 = 0.318). Conclusion: The agreement between p16 IHC and HPV–DNA ISH was fair. However, ISH sensitivity was low. Our findings add to the current data that p16 IHC testing is reliable and may be enough as a stand-alone test for HPV detection in OPSCC.

[1]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[2]  P. Catalano,et al.  Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[3]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[4]  E. Sturgis,et al.  Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Carol Colasacco,et al.  Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists. , 2017, Archives of pathology & laboratory medicine.

[6]  M. Stoler,et al.  HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia , 2017, The American journal of surgical pathology.

[7]  Wei Xu,et al.  Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status. , 2013, International journal of radiation oncology, biology, physics.

[8]  Esther Kim,et al.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  R. Shaw,et al.  Evaluation of Human Papilloma Virus Diagnostic Testing in Oropharyngeal Squamous Cell Carcinoma: Sensitivity, Specificity, and Prognostic Discrimination , 2011, Clinical Cancer Research.

[10]  R. Brakenhoff,et al.  Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways , 2011, International journal of cancer.

[11]  W. Thorstad,et al.  p16 Positive Oropharyngeal Squamous Cell Carcinoma:An Entity With a Favorable Prognosis Regardless of Tumor HPV Status , 2010, The American journal of surgical pathology.

[12]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[13]  A. Hui,et al.  Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J. Webster-Cyriaque,et al.  Oropharyngeal carcinoma in non-smokers and non-drinkers: a role for HPV. , 2009, Oral oncology.

[15]  J. Waldron,et al.  Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. , 2012, International journal of radiation oncology, biology, physics.

[16]  D. Brachman,et al.  Molecular biology of head and neck cancer. , 1994, Seminars in oncology.